These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19631229)

  • 1. Action naming is impaired in Parkinson disease patients.
    Rodríguez-Ferreiro J; Menéndez M; Ribacoba R; Cuetos F
    Neuropsychologia; 2009 Dec; 47(14):3271-4. PubMed ID: 19631229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is action naming better preserved (than object naming) in Alzheimer's disease and why should we ask?
    Druks J; Masterson J; Kopelman M; Clare L; Rose A; Rai G
    Brain Lang; 2006 Sep; 98(3):332-40. PubMed ID: 16843522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of motion content in action naming by Parkinson's disease patients.
    Herrera E; Rodríguez-Ferreiro J; Cuetos F
    Cortex; 2012 Jul; 48(7):900-4. PubMed ID: 21247557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study.
    Seltzer B; Vasterling JJ; Mathias CW; Brennan A
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):122-9. PubMed ID: 11417666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Object naming and action-verb generation in Parkinson's disease: a fMRI study.
    Péran P; Cardebat D; Cherubini A; Piras F; Luccichenti G; Peppe A; Caltagirone C; Rascol O; Démonet JF; Sabatini U
    Cortex; 2009 Sep; 45(8):960-71. PubMed ID: 19368905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact haptic priming in normal aging and Alzheimer's disease: evidence for dissociable memory systems.
    Ballesteros S; Reales JM
    Neuropsychologia; 2004; 42(8):1063-70. PubMed ID: 15093145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verb comprehension and naming in frontotemporal degeneration: the role of the static depiction of actions.
    d'Honincthun P; Pillon A
    Cortex; 2008; 44(7):834-47. PubMed ID: 18489963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the RBANS Visual and Verbal Indices in a sample of neurologically impaired elderly participants.
    Morgan DR; Linck J; Scott J; Adams R; Mold J
    Clin Neuropsychol; 2010 Nov; 24(8):1365-78. PubMed ID: 20954101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease.
    Cotelli M; Manenti R; Cappa SF; Geroldi C; Zanetti O; Rossini PM; Miniussi C
    Arch Neurol; 2006 Nov; 63(11):1602-4. PubMed ID: 17101829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.
    Scholtissen B; Verhey FR; Adam JJ; Weber W; Leentjens AF
    Clin Neuropharmacol; 2006; 29(5):276-85. PubMed ID: 16960473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of category effects in object and action knowledge in dementia of the Alzheimer's type.
    Fung TD; Chertkow H; Murtha S; Whatmough C; Péloquin L; Whitehead V; Templeman FD
    Neuropsychology; 2001 Jul; 15(3):371-9. PubMed ID: 11499992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noun verb dissociation in Parkinson's disease.
    Bertella L; Albani G; Greco E; Priano L; Mauro A; Marchi S; Bulla D; Semenza C
    Brain Cogn; 2002; 48(2-3):277-80. PubMed ID: 12030451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of lexical-semantic impairment and of executive dysfunction on the word reading performance of patients with probable Alzheimer dementia.
    Colombo L; Fonti C; Cappa S
    Neuropsychologia; 2004; 42(9):1192-202. PubMed ID: 15178171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficit of verb generation in nondemented patients with Parkinson's disease.
    Péran P; Rascol O; Démonet JF; Celsis P; Nespoulous JL; Dubois B; Cardebat D
    Mov Disord; 2003 Feb; 18(2):150-6. PubMed ID: 12539207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.